January 8th 2025
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
January 7th 2025
The first death of an American from the H5N1 virus was reported in Louisiana on Monday, though authorities maintain the risk of widespread infection remains low.
January 6th 2025
Sanofi and SK bioscience expand collaboration on pneumococcal conjugate vaccines, including a 21-valent candidate for pediatric populations.
December 18th 2024
Your daily dose of the clinical news you may have missed.
December 10th 2024
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Liver Meeting 2018: 3 Hep C Study Highlights
Find out: why HCV-infected hearts can be viable for non-infected recipients; why screening pregnant women for HCV is worth it; and, how even injection drug users can achieve SVR.
Hepatitis C Treatment Options: 5 Direct Questions
An HCV-infected patient who still injects drugs wants to start direct-acting antiviral therapy. What do guidelines recommend?
4 Good Reasons to Worry about Hep C
Even though hepatitis C cure rates are high, here are 4 issues that should still concern all healthcare providers.
IDWeek 2018: 3 Key Hep C Studies
ICYMI: 3 important studies at IDWeek 2018 highlighted gaps in HCV infection prevention efforts among younger adults, ie, born after the baby boomers.
5 Qs on Managing Hepatitis C in the Young
How much do you know about HCV treatment in children and teens? Take this short, 5-question quiz to find out.
HCV Screening in Younger At-Risk Populations
Universal hepatitis C screening for younger adults may be the next essential step in eradicating the infection suggests pediatric ID specialist Claudia Espinosa, MD, MSc.
HCV in Young Adults and Children: 3 Studies At-a-Glance
Study summaries highlight increased infection rates in young adults; a spike in HCV in reproductive-aged women; and a potential new treatment for HCV in young children.
Improving HCV Care through Telementoring with Project ECHO
Scroll through our quick slideshow to see how 3 recently published studies highlight the need for a telementoring program in HCV care.
Hep C 5-Question Quiz: What Would WHO Do?
HCV testing in HIV-infected men who have sex with men should be conducted every 2 years. True or False?
HCV Interview with Sanjeev Arora, MD, Project ECHO Founder
Expanding HCV care through primary care networks is Dr Arora's passion. The prominent HCV specialist and founder of Project ECHO explains why.
Hep C Quiz: 5 Questions on the News
ICYMI: HCV elimination success, SVR in blacks, transplant delisting, clearance after acute infection-catch up with a quiz.
Acral Anomaly in a Young Boy
Three-year-old boy has rash x7 days on arms and legs plus low-grade fever x10-14 days. Is the eruption anomaly or simply ordinary?
Organ Transplant in the Direct-acting Antiviral Era
Can DAA therapy remove patients from transplant waiting lists? Are HCV-infected livers--and hearts--safe for uninfected organ recipients? Three new studies explain.
Hep C Expert Interview: Gregory T. Everson, MD
Renowned transplant expert Gregory T. Everson, MD, talked with Patient Care about sensitive issues surrounding liver transplant in the era of direct-acting antiviral therapy.
HCV Quiz: 5 Simple Questions, Very Interesting Answers
Sample: Which type of practitioner most often makes the diagnosis of HCV: Gastro? GP? Hepatologist? Other?
Interview with HCV Expert Paul Kwo, MD
Patient Care talked with Dr Kwo about recent updates to hepatitis C management guidelines, challenges in expanding screening, and more.
How to Improve HCV Screening Rates: A 6-Step QI Experience
HCV screening rates improved at one large clinic from 24% to over 90% and were sustained at 1 year. How? With this 6-step intervention.
Hep C Guidance Update Quiz: Special Populations
The newest HCV guidance is out on special populations. Are you up to date? Take our short, 5-question quiz to find out.
Another “Bad” Flu Season: Do You Know Why?
Was it the flu vaccine? The virus itself? An unforeseen combination of both? You'll find out with these 5 questions.
Where Direct Acting Agents Fail, a New Retreatment Strategy May Win
For patients infected with hepatitis C virus who do not respond to direct-acting antiviral agents, results of a new study could mean a much brighter future.
National HCV Elimination Programs Show Early Success in Treatment and Cure
Two new international studies on HCV show elimination programs have high levels of engagement, treatment initiation, and cure rates.
Hep C Quizlet: 5 Short Questions
These 5 questions on HCV infection are a quick brush-up on disease basics and treatment.
Small-town EDs May Have Large Impact on HCV Screening
HCV screening of baby boomers seen in a suburban emergency department found remarkably high seropositivity rates, say authors of a new study.
Elbasvir/grazoprevir Efficacy High in Black Adults with HCV Infection
The current study was one of the largest analyses to date of black participants receiving all-oral DAA treatment.
Rx Shorts: Zoster Vaccination Pearls
Rx Shorts: With 2 shingles vaccines available, questions continue to multiply. Take away 4 small pearls to help answer patient questions and maybe yours.
HCV Screening, Transmission, and Treatment: A Test
This new quiz on hepatitis C tests what you know about mother-to-child transmission, testing at-risk populations, optimal regimens for your sickest patients, and more.
Glecaprevir-pibrentasvir in HCV Genotypes 1 & 3: SVR Rates High after 8 Weeks
The recently-approved HCV treatment produced SVR rates of 95% or greater and discontinuation rates for AEs were extremely low.
Baby Boomer HCV Screening Rates Remain Low, Study Finds
Black and Hispanic boomers had lower odds of HCV screening between 2013-2015, as did female and older members of the 1945-1965 cohort.
Bath Toys: Another Thing To Worry About?
What’s swimming around in kids’ bath water-besides their rubber duckies? And why might it matter?
Test Your HCV IQ: 5 Quick Questions
When to test, how long to treat, what adjustments to make to avoid dangerous drug interactions; test your HCV IQ with a short quiz on a range of topics.